Home Tools
Log in
Cart

Search Result

Search Results for " npc "

20

Compounds

Cat No. Product Name Synonyms Targets
T21060L NPC 567 acetate NPC 567 acetate(109333-26-8 Free base) Bradykinin Receptor
NPC 567 acetate is a bradykinin B2 antagonist and can be used in studies about the treatment of allergic airway disease.
T8638 NPC 15199 FMOC-L-Leucine Others
NPC 15199 (FMOC-L-Leucine) is an anti-inflammatory agent.
T33729 Npc 573 Npc-573,Npc573
Npc 573 is a bioactive chemical.
T77407 Ensituximab NPC-1C,NEO-102,NEO-101
Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer.
T70187 NPC-18915
NPC-18915 is a benzofuran compound, inhibitor of neutophil activation.
T37480 NPC-15437 (hydrochloride)
NPC-15437 (hydrochloride) is a scleclive inhibitor of PKC interacling at the regulatory domain of the enzyme。
T21060 NPC 567
NPC 567 is an antagonist of the bradykinin receptor.
T71024 NPC-16731
NPC-16731 is a Bradykinin antagonist.
T71323 Npc 12626
Npc 12626 is a N-methyl-D-aspartate receptor antagonist; NPC 17742, the (2R,4R,5S)-isomer, is the most potent isomer in the mixture NPC 12626.
T18105 M-PEG-NPC (MW 20000) Others
m-PEG-NPC (MW 20000) is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome sys...
T70576 NPC 17731
NPC 17731 is a bradykinin receptor antagonist.
T70574 NPC 17761
NPC 17761 is a bradykinin receptor antagonist.
T70590 NPC-14695
NPC-14695 is a smooth muscle-selective muscarinic antagonist with bronchodilating activity.
T19553 RPR132595A NPC Others
RPR132595A is an active CPT-11 metabolite, it is generated by cytochrome P-450 3A4 (CYP3A4).
T78069 RPR132595A hydrochloride NPC hydrochloride Drug Metabolite
RPR132595A (NPC) hydrochloride, an active metabolite of CPT-11, is produced via cytochrome P-450 3A4 (CYP3A4) metabolism and is ultimately eliminated via urinary excretion [1].
T71321 (S)-VU0637120 Others
(S)-VU0637120 is a selective neuropeptide Y(4)R-mutant antagonist used in the study of metabolic disorders.
T70588 Tazemetostat HCl
Tazemetostat HCl is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. Treatment of...
T70186 Methazolamide-d6
Methazolamide-d6 is intended for use as an internal standard for the quantification of methazolamide by GC- or LC-MS. Methazolamide is a carbonic anhydrase inhibitor. It reduces intraocular pressure and cerebrospinal flu...
T70572 CHF-2060
CHF-2060 is a novel acetylcholinesterase inhibitor.
T71023 MI-888 free base
MI-888 is a potent MDM2 inhibitor (Ki = 0.44 nM) with a superior pharmacokinetic profile and enhanced in vivo efficacy. MI-888 is capable of achieving rapid, complete, and durable tumor regression in two types of xenogra...
1 2
TargetMol